MedPath

Effect of Docosahexaenoic Acid (DHA) use on the incidence of eye disease of preterm babies

Not Applicable
Conditions
Retinopathy of Prematurity
C11.768
Registration Number
RBR-523wzcb
Lead Sponsor
Secretaria Estadual da Saúde de Santa Catarina
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruitment completed
Sex
Not specified
Target Recruitment
Not specified
Inclusion Criteria

Premature babies with mothers older than 18 years of age; up to 33 gestational age; who were born at Maternidade Darcy Vargas from March 1 2020 to August 31 2022 whose mothers have signed the Free and Informed Consent Form

Exclusion Criteria

Premature babies with congenital eye malformation; whose mothers have been supplemented with omega-3 and who have had infectious diseases

Study & Design

Study Type
Intervention
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath